Incidence and trends of skin cancer in the United States, 1999-2016. Design and rationale of MASTERKEY-115 phase II trial of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in patients ...
(HealthDay News) — Lesion-directed screening (LDS) has a similar skin cancer detection rate as total-body examination (TBE) but is substantially less time-consuming, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results